Kenneth Bahrt - Net Worth and Insider Trading
Kenneth Bahrt Net Worth
The estimated net worth of Kenneth Bahrt is at least $4 Million dollars as of 2024-11-13. Kenneth Bahrt is the SVP, Chief Medical Officer of Seventy Seven Energy Inc and owns about 100,000 shares of Seventy Seven Energy Inc (SVNT) stock worth over $4 Million. Kenneth Bahrt is also the Chief Medical Officer of Outlook Therapeutics Inc and owns about 295 shares of Outlook Therapeutics Inc (OTLK) stock worth over $1,850. Details can be seen in Kenneth Bahrt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Bahrt has not made any transactions after 2018-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Bahrt
Kenneth Bahrt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Bahrt owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Kenneth Bahrt’s form 4 insider trades.
Insider Ownership Summary of Kenneth Bahrt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2018-06-25 | Chief Medical Officer |
Kenneth Bahrt Latest Holdings Summary
Kenneth Bahrt currently owns a total of 2 stocks. Among these stocks, Kenneth Bahrt owns 100,000 shares of Seventy Seven Energy Inc (SVNT) as of October 16, 2013, with a value of $4 Million and a weighting of 99.95%. Kenneth Bahrt also owns 295 shares of Outlook Therapeutics Inc (OTLK) as of June 25, 2018, with a value of $1,850 and a weighting of 0.05%.
Latest Holdings of Kenneth Bahrt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SVNT | Seventy Seven Energy Inc | 2013-10-16 | 100,000 | 40.05 | 4,005,000 |
| OTLK | Outlook Therapeutics Inc | 2018-06-25 | 295 | 6.27 | 1,850 |
Holding Weightings of Kenneth Bahrt
Kenneth Bahrt Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Bahrt has made a total of 0 transactions in Seventy Seven Energy Inc (SVNT) over the past 5 years. The most-recent trade in Seventy Seven Energy Inc is the sale of 78,211 shares on October 16, 2013, which brought Kenneth Bahrt around $6,257.
According to the SEC Form 4 filings, Kenneth Bahrt has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 48 shares on June 25, 2018, which brought Kenneth Bahrt around $6,545.
Insider Trading History of Kenneth Bahrt
- 1
Kenneth Bahrt Trading Performance
Kenneth Bahrt Ownership Network
Ownership Network List of Kenneth Bahrt
Ownership Network Relation of Kenneth Bahrt
Kenneth Bahrt Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Kenneth Bahrt is the Chief Medical Officer of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Kenneth Bahrt made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Kenneth Bahrt Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Bahrt. You might contact Kenneth Bahrt via mailing address: One Tower Center Blvd, East Brunswick Nj 08619.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
